日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiomyocyte derived extracellular mitochondria in activation of macrophages during oxidative stress

心肌细胞来源的细胞外线粒体在氧化应激过程中激活巨噬细胞

Shrestha, Lenee; Gu, Haiwei; Satterlee, Taylor; He, Suizi; Chen, Qin M

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025-26 Influenza Season

利用疫苗预防和控制季节性流感:美国免疫实践咨询委员会的建议——2025-2026流感季

Grohskopf, Lisa A; Blanton, Lenee H; Ferdinands, Jill M; Reed, Carrie; Dugan, Vivien G; Daskalakis, Demetre C

Multidisciplinary Evaluation for COPD Management

慢性阻塞性肺疾病管理的多学科评估

Nathani, Avantika; Nanah, Abdelrahman; Al-Jaghbeer, Mohammed J; Meli, Yvonne M; Wisen, Danielle; Marsili, Lenee; Marlow, Scott; Connolly, Janet; Machuzak, Michael; Gildea, Thomas R; Gillespie, Colin; Murthy, Sudish; Ahmad, Usman; Mehta, Atul C; Aboussouan, Loutfi S; Yadav, Ruchi; Attaway, Amy; Tejwani, Vickram; Stoller, James K; Wang, Yifan; Wang, Xiaofeng; Hatipoğlu, Umur

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season

利用疫苗预防和控制季节性流感:美国免疫实践咨询委员会的建议——2024-2025流感季

Grohskopf, Lisa A; Ferdinands, Jill M; Blanton, Lenee H; Broder, Karen R; Loehr, Jamie

Del Nido cardioplegia or potassium induces Nrf2 and protects cardiomyocytes against oxidative stress

Del Nido 心脏停搏液或钾诱导 Nrf2 表达,并保护心肌细胞免受氧化应激损伤。

Hongting Diao ,Wujing Dai ,Daniel Wurm ,Yingying Lu ,Lenee Shrestha ,Amy He ,Raymond K Wong ,Qin M Chen

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022-23 Influenza Season

利用疫苗预防和控制季节性流感:美国免疫实践咨询委员会的建议——2022-2023流感季

Grohskopf, Lisa A; Blanton, Lenee H; Ferdinands, Jill M; Chung, Jessie R; Broder, Karen R; Talbot, H Keipp; Morgan, Rebecca L; Fry, Alicia M

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

美国VISION网络研究显示,疫苗对中重度新冠肺炎患者的有效性正在减弱:一项针对检测结果为阴性的病例对照研究

Ferdinands, Jill M; Rao, Suchitra; Dixon, Brian E; Mitchell, Patrick K; DeSilva, Malini B; Irving, Stephanie A; Lewis, Ned; Natarajan, Karthik; Stenehjem, Edward; Grannis, Shaun J; Han, Jungmi; McEvoy, Charlene; Ong, Toan C; Naleway, Allison L; Reese, Sarah E; Embi, Peter J; Dascomb, Kristin; Klein, Nicola P; Griggs, Eric P; Liao, I-Chia; Yang, Duck-Hye; Fadel, William F; Grisel, Nancy; Goddard, Kristin; Patel, Palak; Murthy, Kempapura; Birch, Rebecca; Valvi, Nimish R; Arndorfer, Julie; Zerbo, Ousseny; Dickerson, Monica; Raiyani, Chandni; Williams, Jeremiah; Bozio, Catherine H; Blanton, Lenee; Link-Gelles, Ruth; Barron, Michelle A; Gaglani, Manjusha; Thompson, Mark G; Fireman, Bruce

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022

在Delta和Omicron变异株占主导地位期间,mRNA疫苗对成人COVID-19相关急诊就诊、紧急护理和住院治疗的2剂和3剂疫苗效力逐渐减弱——VISION网络,10个州,2021年8月至2022年1月

Ferdinands, Jill M; Rao, Suchitra; Dixon, Brian E; Mitchell, Patrick K; DeSilva, Malini B; Irving, Stephanie A; Lewis, Ned; Natarajan, Karthik; Stenehjem, Edward; Grannis, Shaun J; Han, Jungmi; McEvoy, Charlene; Ong, Toan C; Naleway, Allison L; Reese, Sarah E; Embi, Peter J; Dascomb, Kristin; Klein, Nicola P; Griggs, Eric P; Konatham, Deepika; Kharbanda, Anupam B; Yang, Duck-Hye; Fadel, William F; Grisel, Nancy; Goddard, Kristin; Patel, Palak; Liao, I-Chia; Birch, Rebecca; Valvi, Nimish R; Reynolds, Sue; Arndorfer, Julie; Zerbo, Ousseny; Dickerson, Monica; Murthy, Kempapura; Williams, Jeremiah; Bozio, Catherine H; Blanton, Lenee; Verani, Jennifer R; Schrag, Stephanie J; Dalton, Alexandra F; Wondimu, Mehiret H; Link-Gelles, Ruth; Azziz-Baumgartner, Eduardo; Barron, Michelle A; Gaglani, Manjusha; Thompson, Mark G; Fireman, Bruce

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021

2021年1月至9月,九个州对免疫功能低下成年人接种两剂mRNA新冠疫苗预防新冠肺炎相关住院的有效性研究

Embi, Peter J; Levy, Matthew E; Naleway, Allison L; Patel, Palak; Gaglani, Manjusha; Natarajan, Karthik; Dascomb, Kristin; Ong, Toan C; Klein, Nicola P; Liao, I-Chia; Grannis, Shaun J; Han, Jungmi; Stenehjem, Edward; Dunne, Margaret M; Lewis, Ned; Irving, Stephanie A; Rao, Suchitra; McEvoy, Charlene; Bozio, Catherine H; Murthy, Kempapura; Dixon, Brian E; Grisel, Nancy; Yang, Duck-Hye; Goddard, Kristin; Kharbanda, Anupam B; Reynolds, Sue; Raiyani, Chandni; Fadel, William F; Arndorfer, Julie; Rowley, Elizabeth A; Fireman, Bruce; Ferdinands, Jill; Valvi, Nimish R; Ball, Sarah W; Zerbo, Ousseny; Griggs, Eric P; Mitchell, Patrick K; Porter, Rachael M; Kiduko, Salome A; Blanton, Lenee; Zhuang, Yan; Steffens, Andrea; Reese, Sarah E; Olson, Natalie; Williams, Jeremiah; Dickerson, Monica; McMorrow, Meredith; Schrag, Stephanie J; Verani, Jennifer R; Fry, Alicia M; Azziz-Baumgartner, Eduardo; Barron, Michelle A; Thompson, Mark G; DeSilva, Malini B

Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection

针对假型严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 的中和抗体反应在mRNA-1273和BNT162b2冠状病毒病2019 (COVID-19) 疫苗之间以及SARS-CoV-2感染史之间存在差异

Tyner, Harmony L; Burgess, Jefferey L; Grant, Lauren; Gaglani, Manjusha; Kuntz, Jennifer L; Naleway, Allison L; Thornburg, Natalie J; Caban-Martinez, Alberto J; Yoon, Sarang K; Herring, Meghan K; Beitel, Shawn C; Blanton, Lenee; Nikolich-Zugich, Janko; Thiese, Matthew S; Pleasants, Jessica Flores; Fowlkes, Ashley L; Lutrick, Karen; Dunnigan, Kayan; Yoo, Young M; Rose, Spencer; Groom, Holly; Meece, Jennifer; Wesley, Meredith G; Schaefer-Solle, Natasha; Louzado-Feliciano, Paola; Edwards, Laura J; Olsho, Lauren E W; Thompson, Mark G